QC
CARL

Quadrature Capital’s Carlsmed CARL Stock Holding History

Quadrature Capital’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,352
Closed -$121K – 2161
2026
Q1 		$121K Buy
+13,352
New +$161K ﹤0.01% 1198

Other funds holding CARL

JT
Jupiter Topco New York $245B AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KC
KCM Capital Shawnee, Kansas $618M AUM
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrature Capital's CARL Position: Q2 2026 in Review

Quadrature Capital sold out of Carlsmed (CARL) in Q2 2026, closing a stake of 13,352 shares — an estimated $121K sold.

Quadrature Capital first reported a position in CARL in Q1 2026 and held it in 1 quarter. The position peaked at $121K in Q1 2026. 75 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • Quadrature Capital reported no remaining Carlsmed position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 13,352 Carlsmed shares in Q2 2026, an estimated $121K.
  • Quadrature Capital first reported a position in Carlsmed in Q1 2026 and held it in 1 quarter.
  • Quadrature Capital's Carlsmed position peaked at $121K in Q1 2026.
  • 75 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.